AMGN
63
6
PCAR
52
2
NFLX
59
-2
WYNN
46
5
CLX
46
2
RF
50
2
MSI
57
13
AMP
72
3
HIG
72
2
LRCX
59
6
TXN
39
3
FTI
86
2
NOV
54
5
CTSH
44
2
RIG
44
3
LOW
61
5
HBAN
56
2
AVGO
42
2
FIS
48
5
XEL
58
3
AMGN
63
6
PCAR
52
2
NFLX
59
-2
WYNN
46
5
CLX
46
2
RF
50
2
MSI
57
13
AMP
72
3
HIG
72
2
LRCX
59
6
TXN
39
3
FTI
86
2
NOV
54
5
CTSH
44
2
RIG
44
3
LOW
61
5
HBAN
56
2
AVGO
42
2
FIS
48
5
XEL
58
3
Financhill
Back

Teva Pharmaceutical Industries Quote, Financials, Valuation and Earnings

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here
Sell
48

TEVJF
Teva Pharmaceutical Industries

Last Price:
11.75
Seasonality Move:
-8.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Election Shock on August 19th?

Click here now to see the evidence I've gathered.

Teva Pharmaceutical Industries Price Quote

$11.75

Teva Pharmaceutical Industries Key Stats

Sell
48
Teva Pharmaceutical Industries (TEVJF) is a Sell
Day range:
$11.75 - $11.75
52-week range:
$7.03 - $15.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.83
P/B ratio:
1.76%
Volume:
0
Avg. volume:
65
1-year change:
40.72%
Market cap:
$13.2B
Revenue:
$15.8B
EPS:
$-0.47

How Much Does Teva Pharmaceutical Industries Make?

Is Teva Pharmaceutical Industries Growing As A Company?

Teva Pharmaceutical Industries Stock Price Performance

What Is Teva Pharmaceutical Industries 52-Week High & Low?

Teva Pharmaceutical Industries Price To Free Cash Flow

Is It Risky To Buy Teva Pharmaceutical Industries?

Is Teva Pharmaceutical Industries Cash Flow Positive?

Teva Pharmaceutical Industries Return On Invested Capital

  • Is Management Doing A Good Job?
    TEVJF return on invested capital is -1.96%
  • What Is Teva Pharmaceutical Industries Return On Assets?
    ROA measures how assets are converting to revenues and is -1.29%
  • What Is TEVJF Return On Equity?
    ROE is a measure of profitability and is -6.89%

Teva Pharmaceutical Industries Earnings Date & Stock Price

Teva Pharmaceutical Industries Competitors

Teva Pharmaceutical Industries Dividend Yield

Data Unavailable

Teva Pharmaceutical Industries Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 14.78% 11.15%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many TEVJF shares are owned by institutional investors?
    68.1M TEVJF shares are owned by institutional investors
  • How many TEVJF shares are owned by insiders?
    0 TEVJF shares are owned by insiders